Gene Therapy Market

Gene Therapy Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

230

Base Year:

2024

Nov - 2024

Format:

Report Code:

VMR-3387

Segments Covered

By Vector Type Viral Vector, Non-Viral Vector
By Gene Type Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors
By Application Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2024
Forecast Years:	2025 - 2034
Historical Years:	2019 - 2023
Revenue 2024:	USD XX Billion
Revenue 2034:	USD XX Billion
Revenue CAGR (2025 - 2034):	30%
Fastest Growing Region (2025 - 2034)	North America
Largest Region (2024):	XX

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Gene Therapy Market - Segment Analysis
1. Overview
2. Global Gene Therapy Market, 2016 - 2028 (USD Million)
3. Global Gene Therapy Market - by Vector Type
  1. By Viral Vector
  2. By Non-Viral Vector
4. Global Gene Therapy Market - by Gene Type
  1. By Antigen
  2. By Cytokine
  3. By Tumor Suppressor
  4. By Suicide
  5. By Deficiency
  6. By Growth Factors
  7. By Receptors
5. Global Gene Therapy Market - by Application
  1. By Oncological Disorders
  2. By Rare Diseases
  3. By Cardiovascular Diseases
  4. By Neurological Disorders
  5. By Infectious Disease
6. Global Gene Therapy Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Gene Therapy Market - Segment Analysis
1. Overview
2. North America Gene Therapy Market, 2016 - 2028 (USD Million)
3. North America Gene Therapy Market, by Vector Type
  1. By Viral Vector
  2. By Non-Viral Vector
4. North America Gene Therapy Market, by Gene Type
  1. By Antigen
  2. By Cytokine
  3. By Tumor Suppressor
  4. By Suicide
  5. By Deficiency
  6. By Growth Factors
  7. By Receptors
5. North America Gene Therapy Market, by Application
  1. By Oncological Disorders
  2. By Rare Diseases
  3. By Cardiovascular Diseases
  4. By Neurological Disorders
  5. By Infectious Disease
6. North America Gene Therapy Market, by Country
  1. U.S.
    1. U.S. Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. U.S. Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. U.S. Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  2. Canada
    1. Canada Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Canada Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Canada Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  3. Mexico
    1. Mexico Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Mexico Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Mexico Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
Europe Gene Therapy Market - Segment Analysis
1. Overview
2. Europe Gene Therapy Market, 2016 - 2028 (USD Million)
3. Europe Gene Therapy Market, by Vector Type
  1. By Viral Vector
  2. By Non-Viral Vector
4. Europe Gene Therapy Market, by Gene Type
  1. By Antigen
  2. By Cytokine
  3. By Tumor Suppressor
  4. By Suicide
  5. By Deficiency
  6. By Growth Factors
  7. By Receptors
5. Europe Gene Therapy Market, by Application
  1. By Oncological Disorders
  2. By Rare Diseases
  3. By Cardiovascular Diseases
  4. By Neurological Disorders
  5. By Infectious Disease
6. Europe Gene Therapy Market, by Country
  1. Germany
    1. Germany Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Germany Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Germany Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  2. UK
    1. UK Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. UK Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. UK Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  3. France
    1. France Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. France Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. France Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  4. Spain
    1. Spain Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Spain Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Spain Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  5. Italy
    1. Italy Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Italy Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Italy Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  6. BENELUX
    1. BENELUX Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. BENELUX Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. BENELUX Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  7. Rest of Europe
    1. Rest Of Europe Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Rest Of Europe Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Rest Of Europe Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
Asia Pacific Gene Therapy Market - Segment Analysis
1. Overview
2. Asia Pacific Gene Therapy Market, 2016 - 2028 (USD Million)
3. Asia Pacific Gene Therapy Market, by Vector Type
  1. By Viral Vector
  2. By Non-Viral Vector
4. Asia Pacific Gene Therapy Market, by Gene Type
  1. By Antigen
  2. By Cytokine
  3. By Tumor Suppressor
  4. By Suicide
  5. By Deficiency
  6. By Growth Factors
  7. By Receptors
5. Asia Pacific Gene Therapy Market, by Application
  1. By Oncological Disorders
  2. By Rare Diseases
  3. By Cardiovascular Diseases
  4. By Neurological Disorders
  5. By Infectious Disease
6. Asia Pacific Gene Therapy Market, by Country
  1. China
    1. China Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. China Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. China Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  2. Japan
    1. Japan Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Japan Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Japan Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  3. India
    1. India Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. India Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. India Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  4. South Korea
    1. South Korea Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. South Korea Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. South Korea Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  5. South East Asia
    1. South East Asia Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. South East Asia Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. South East Asia Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Rest of Asia Pacific Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Rest of Asia Pacific Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
Latin America Gene Therapy Market - Segment Analysis
1. Overview
2. Latin America Gene Therapy Market, 2016 - 2028 (USD Million)
3. Latin America Gene Therapy Market, by Vector Type
  1. By Viral Vector
  2. By Non-Viral Vector
4. Latin America Gene Therapy Market, by Gene Type
  1. By Antigen
  2. By Cytokine
  3. By Tumor Suppressor
  4. By Suicide
  5. By Deficiency
  6. By Growth Factors
  7. By Receptors
5. Latin America Gene Therapy Market, by Application
  1. By Oncological Disorders
  2. By Rare Diseases
  3. By Cardiovascular Diseases
  4. By Neurological Disorders
  5. By Infectious Disease
6. Latin America Gene Therapy Market, by Country
  1. Brazil
    1. Brazil Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Brazil Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Brazil Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  2. Argentina
    1. Argentina Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Argentina Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Argentina Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  3. Rest of Latin America
    1. Rest of Latin America Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Rest of Latin America Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Rest of Latin America Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
Middle East & Africa Gene Therapy Market - Segment Analysis
1. Overview
2. Middle East & Africa Gene Therapy Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Gene Therapy Market, by Vector Type
  1. By Viral Vector
  2. By Non-Viral Vector
4. Middle East & Africa Gene Therapy Market, by Gene Type
  1. By Antigen
  2. By Cytokine
  3. By Tumor Suppressor
  4. By Suicide
  5. By Deficiency
  6. By Growth Factors
  7. By Receptors
5. Middle East & Africa Gene Therapy Market, by Application
  1. By Oncological Disorders
  2. By Rare Diseases
  3. By Cardiovascular Diseases
  4. By Neurological Disorders
  5. By Infectious Disease
6. Middle East & Africa Gene Therapy Market, by Country
  1. GCC Countries
    1. GCC Countries Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. GCC Countries Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. GCC Countries Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  2. South Africa
    1. South Africa Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. South Africa Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. South Africa Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Gene Therapy Market, By Vector Type
      1. By Viral Vector
      2. By Non-Viral Vector
    2. Rest of Middle East & Africa Gene Therapy Market, By Gene Type
      1. By Antigen
      2. By Cytokine
      3. By Tumor Suppressor
      4. By Suicide
      5. By Deficiency
      6. By Growth Factors
      7. By Receptors
    3. Rest of Middle East & Africa Gene Therapy Market, By Application
      1. By Oncological Disorders
      2. By Rare Diseases
      3. By Cardiovascular Diseases
      4. By Neurological Disorders
      5. By Infectious Disease
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Adaptimmune Therapeutics Plc.
2. Anchiano Therapeutics Ltd.
3. Achieve Life Sciences Inc.
4. Adverum Biotechnologies Inc.
5. Abeona Therapeutics Inc.
6. Applied Genetic Technologies Corporation
7. Arbutus Biopharma Corporation
8. Audentes Therapeutics Inc.
9. AveXis Inc.
10. Bluebird Bio Inc.
11. Celgene Corporation
12. CRISPR Therapeutics AG
13. Editas Medicine Inc.
14. Editas Medicine Inc.
15. GlaxoSmithKline Plc.
16. Intellia Therapeutics Inc.
17. Merck & Co. Inc.
18. Novartis AG
19. REGENXBIO Inc.
20. Spark Therapeutics Inc.
21. Sangamo Therapeutics Inc.
22. Uniqure N. V.
23. Voyager Therapeutics Inc.
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Gene Therapy in terms of revenue?

The global Gene Therapy valued at USD XX Billion in 2024 and is expected to reach USD XX Billion in 2034 growing at a CAGR of 30%.

Which are the prominent players in the market?

The prominent players in the market are Adaptimmune Therapeutics Plc., Anchiano Therapeutics Ltd., Achieve Life Sciences, Inc., Adverum Biotechnologies, Inc., Abeona Therapeutics Inc., Applied Genetic Technologies Corporation, Arbutus Biopharma Corporation, Audentes Therapeutics, Inc., AveXis, Inc., Bluebird Bio, Inc., Celgene Corporation, CRISPR Therapeutics AG, Editas Medicine, Inc., Editas Medicine, Inc., GlaxoSmithKline Plc., Intellia Therapeutics, Inc., Merck & Co., Inc., Novartis AG, REGENXBIO Inc., Spark Therapeutics, Inc., Sangamo Therapeutics, Inc., Uniqure N. V., Voyager Therapeutics, Inc. .

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 30% between 2025 and 2034.

What are the driving factors fueling the growth of the market.

The driving factors of the Gene Therapy include

Which region accounted for the largest share in the market?

XX was the leading regional segment of the Gene Therapy in 2024.

Gene Therapy Market

Gene Therapy Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Gene Therapy in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Gene Therapy Market

Gene Therapy Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Gene Therapy in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Gene Therapy Market

Vantage Point Interactive Dashboard